Cross-sectional study compares SARS-CoV-2 antibody levels in naturally infected and vaccinated cohorts, highlighting immunological differences to inform public health vaccination policies.
Natural infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) or vaccination triggers antibody production against key viral antigens. However, there is limited evidence on the levels of antibodies produced in naturally infected individuals compared to those vaccinated in Ethiopia. Therefore, we aimed to detect and compare SARS-CoV-2 antibodies produced by naturally infected and vaccinated individuals.
No takes yet. Share an insight, caveat, or question.
Bashea et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: